What is the recommended treatment for pediatric pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Pneumonia Treatment Guidelines

The recommended first-line treatment for pediatric community-acquired pneumonia is oral amoxicillin at 90 mg/kg/day in 2 doses for presumed bacterial pneumonia, and azithromycin for presumed atypical pneumonia. 1, 2

Age-Based Treatment Recommendations

Outpatient Treatment

  • For children under 5 years with presumed bacterial pneumonia: oral amoxicillin 90 mg/kg/day in 2 doses 3, 1
  • For children 5 years and older with presumed bacterial pneumonia: oral amoxicillin 90 mg/kg/day in 2 doses (maximum 4 g/day) 3, 1
  • For children with presumed atypical pneumonia (any age): oral azithromycin 10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5 1, 4
  • For children with presumed bacterial pneumonia who do not have clinical evidence distinguishing bacterial from atypical pneumonia, a macrolide can be added to a β-lactam antibiotic for empiric therapy 3

Inpatient Treatment

  • For fully immunized children: ampicillin or penicillin G; alternatives include ceftriaxone or cefotaxime 3
  • For children not fully immunized against H. influenzae type b and S. pneumoniae: ceftriaxone or cefotaxime 3
  • For suspected methicillin-resistant Staphylococcus aureus (MRSA): add vancomycin or clindamycin 3
  • For suspected atypical pneumonia in hospitalized patients: add azithromycin 3

Pathogen-Specific Treatment

Streptococcus pneumoniae

  • Preferred: oral amoxicillin (90 mg/kg/day in 2 doses) 3, 1
  • Alternative for penicillin-allergic patients: oral cephalosporins with substantial activity against S. pneumoniae (cefpodoxime, cefprozil, or cefuroxime) 1, 2

Mycoplasma pneumoniae/Chlamydophila pneumoniae

  • Preferred: oral azithromycin (10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5) 3, 4
  • Alternatives: clarithromycin (15 mg/kg/day in 2 doses) or erythromycin (40 mg/kg/day in 4 doses) 3
  • For children >7 years old: doxycycline (2-4 mg/kg/day in 2 doses) can be considered 3

Haemophilus influenzae

  • For β-lactamase negative strains: amoxicillin (75-100 mg/kg/day in 3 doses) 3
  • For β-lactamase producing strains: amoxicillin-clavulanate (amoxicillin component, 45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses) 3, 2

Staphylococcus aureus

  • For methicillin-susceptible S. aureus (MSSA): oral cephalexin (75-100 mg/kg/day in 3-4 doses) 3
  • For methicillin-resistant S. aureus (MRSA): oral clindamycin (30-40 mg/kg/day in 3-4 doses) if susceptible 3
  • For MRSA resistant to clindamycin: oral linezolid (30 mg/kg/day in 3 doses for children <12 years and 20 mg/kg/day in 2 doses for children ≥12 years) 3

Duration of Treatment

  • For uncomplicated pneumonia, a 5-day course of antibiotics is recommended 1, 5
  • Recent high-quality evidence shows that 5 days of high-dose amoxicillin is as effective as 10 days for uncomplicated community-acquired pneumonia in children not requiring hospitalization 6, 5
  • For pneumonia with complications such as parapneumonic effusion, longer treatment (2-4 weeks) may be necessary 1

Assessment of Treatment Response

  • Children should demonstrate clinical improvement within 48-72 hours of starting appropriate therapy 1, 2
  • If no improvement is seen within this timeframe, reevaluation is necessary, including consideration of alternative diagnoses, resistant pathogens, or complications 1, 2

Common Pitfalls to Avoid

  • Underdosing amoxicillin: Using standard doses (40-45 mg/kg/day) rather than the recommended higher doses (90 mg/kg/day) for pneumonia may lead to treatment failure due to resistant pneumococci 1, 7
  • Inappropriate use of macrolides as first-line therapy for presumed bacterial pneumonia in young children, as resistance rates may be higher 2
  • Failing to reassess children not improving within 48-72 hours 1, 2
  • Using unnecessarily prolonged antibiotic courses, which can contribute to antibiotic resistance and adverse effects 6, 8

Special Considerations

  • For children with non-serious allergic reactions to amoxicillin, consider oral cephalosporins with substantial activity against S. pneumoniae under medical supervision 3
  • For children with severe penicillin allergies, consider macrolides (for atypical pathogens) or linezolid/clindamycin (for suspected S. pneumoniae or S. aureus) 3
  • For influenza pneumonia, oseltamivir or zanamivir should be considered based on age appropriateness 3

References

Guideline

Pediatric Pneumonia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Antibiotic Treatment for Pediatric Community-Acquired Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.